AGM/EGMMay 22, 2026, 06:08 AM
Innate Pharma Shareholders Approve All Resolutions at 2026 AGM
AI Summary
Innate Pharma SA announced the voting results from its Annual General Meeting (AGM) held on May 21, 2026, in Marseille. Shareholders approved all resolutions presented at the meeting. The AGM saw a quorum of 37.136%, with 94 votes cast out of 34,872,293 shares.
Key Highlights
- Innate Pharma's Annual General Meeting (AGM) was held on May 21, 2026, in Marseille.
- All resolutions presented at the AGM were approved by shareholders.
- A total of 94 votes were cast at the meeting.
- The total number of shares giving voting rights was 34,872,293, representing 34,921,313 voting rights.
- The quorum for the AGM was 37.136%.
- Results and related documents will be available on the company's website.
Price Impact
More from IPHA